The trajectory of Viagra, originally marketed by copyright, presents a complex case study for backers considering the pharmaceutical arena . Despite its initial success and generation of vast in sales, the intellectual property end has opened the way for generic medications, substantially reducing profit opportunities. This change raises doubts abo